Target intelligence / Profile preview

Ribosomal protein S3a pseudogene 24 (RPS3AP24)

Target
RPS3AP24
Molecular classification
Other (processed pseudogene)
01

Overview

Ribosomal protein S3a pseudogene 24 (RPS3AP24) is a non-coding genetic element classified as a processed pseudogene. Processed pseudogenes arise when reverse-transcribed mRNA is reintegrated into the genome, typically lacking regulatory sequences necessary for expression. RPS3AP24 is homologous to the gene encoding ribosomal protein S3A (RPS3A), but unlike the functional gene, it does not produce protein and does not participate in ribosomal function or cellular processes. Many pseudogenes, including RPS3AP24, are remnants of evolutionary events and do not have a well-characterized function[4][7]. There is no evidence suggesting that RPS3AP24 serves as a therapeutic target, nor is it implicated in disease, biological regulatory roles, or drug actions. If you require structured information for the functional protein (RPS3A), that entry would describe a ribosomal component with diverse cellular roles, but this does not apply to the pseudogene RPS3AP24[3][5][6].

Other names
RPS3A_10_762ribosomal protein S3a pseudogene 24RPS3AP24
02

Biological functions

Other (no known biological function; does not encode a functional protein[4][7])
03

Disease associations

Other (no established disease roles; pseudogenes sometimes have regulatory functions, but none are documented for RPS3AP24)

Beyond the preview

Go deeper on Ribosomal protein S3a pseudogene 24 (RPS3AP24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S3a pseudogene 24 (RPS3AP24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call